Establishing performance characteristics for positive control article selection in drug self-administration studies
The selection of a controlled substance (CS) for use as the positive control article in a nonclinical drug abuse liability (DAL) assessment study should be contemplated carefully and with full understanding of the stated intent of the study design. Any CS that can maintain day-to-day stable baseline...
Gespeichert in:
Veröffentlicht in: | Journal of pharmacological and toxicological methods 2019-05, Vol.97, p.13-23 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 23 |
---|---|
container_issue | |
container_start_page | 13 |
container_title | Journal of pharmacological and toxicological methods |
container_volume | 97 |
creator | Gauvin, David V. Zimmermann, Zachary J. Kallman, Mary Jeanne |
description | The selection of a controlled substance (CS) for use as the positive control article in a nonclinical drug abuse liability (DAL) assessment study should be contemplated carefully and with full understanding of the stated intent of the study design. Any CS that can maintain day-to-day stable baseline responding of voluntary intravenous intakes in animals may be selected under the current guidelines. Schedule I – IV CNS stimulants, depressants, and sedative/hypnotics can serve as maintenance drugs in these protocols, but not all of these compounds will provide comparatively efficient, robust, and stable daily intakes. Each Sponsor is directed to select a positive control article and training dose that will provide the most balanced, predictive, and scientifically-sound comparison consistent with the mechanism of action or therapeutic target of the test article. The SA study design is not a “one-size-fits-all” assay. This is a discussion of the critical design factors to be considered in selecting the most appropriate positive control article to use for a SA study. |
doi_str_mv | 10.1016/j.vascn.2019.02.007 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2185876983</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1056871919300097</els_id><sourcerecordid>2185876983</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-aa9ecf63d1178fb9afe34830964f35d48824891ddbc5de1a87d6796681da7f63</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMofv8CQXr00po0bZMcPIj4BYIXD95CNplqlrZZM-mC_96sqx49zTDv-84wDyFnjFaMsu5yWa0N2qmqKVMVrStKxQ45ZFLwspHydTf3tO1KKZg6IEeIS0opV6zZJwecCiVUWx8SvMVkFoPHdz-9FSuIfYijmSwU9t1EYxNEj8lbLLJQrAL65NdZDFOKYShMzNoABcIANvkwFX4qXJzfNpO-NG70U85H861hmp0HPCF7vRkQTn_qMXm5u325eSifnu8fb66fSstlm0pjFNi-444xIfuFMj3wRnKquqbnrcs_1o1UzLmFbR0wI4XrhOo6yZwROXdMLrZrVzF8zIBJjx4tDIOZIMyoayZbKTolebbyrdXGgBih16voRxM_NaN6A1sv9TdsvYGtaa0z7Jw6_zkwL0Zwf5lfutlwtTVA_nLtIWq0HjJc52PGpV3w_x74AnFnlTI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2185876983</pqid></control><display><type>article</type><title>Establishing performance characteristics for positive control article selection in drug self-administration studies</title><source>Access via ScienceDirect (Elsevier)</source><creator>Gauvin, David V. ; Zimmermann, Zachary J. ; Kallman, Mary Jeanne</creator><creatorcontrib>Gauvin, David V. ; Zimmermann, Zachary J. ; Kallman, Mary Jeanne</creatorcontrib><description>The selection of a controlled substance (CS) for use as the positive control article in a nonclinical drug abuse liability (DAL) assessment study should be contemplated carefully and with full understanding of the stated intent of the study design. Any CS that can maintain day-to-day stable baseline responding of voluntary intravenous intakes in animals may be selected under the current guidelines. Schedule I – IV CNS stimulants, depressants, and sedative/hypnotics can serve as maintenance drugs in these protocols, but not all of these compounds will provide comparatively efficient, robust, and stable daily intakes. Each Sponsor is directed to select a positive control article and training dose that will provide the most balanced, predictive, and scientifically-sound comparison consistent with the mechanism of action or therapeutic target of the test article. The SA study design is not a “one-size-fits-all” assay. This is a discussion of the critical design factors to be considered in selecting the most appropriate positive control article to use for a SA study.</description><identifier>ISSN: 1056-8719</identifier><identifier>EISSN: 1873-488X</identifier><identifier>DOI: 10.1016/j.vascn.2019.02.007</identifier><identifier>PMID: 30797952</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Abuse liability testing ; DEA ; Drug reinforcement ; Drug scheduling ; FDA ; Harmonized guidelines ; Rat ; Self-administration</subject><ispartof>Journal of pharmacological and toxicological methods, 2019-05, Vol.97, p.13-23</ispartof><rights>2019 Elsevier Inc.</rights><rights>Copyright © 2019 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-aa9ecf63d1178fb9afe34830964f35d48824891ddbc5de1a87d6796681da7f63</citedby><cites>FETCH-LOGICAL-c385t-aa9ecf63d1178fb9afe34830964f35d48824891ddbc5de1a87d6796681da7f63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.vascn.2019.02.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27928,27929,45999</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30797952$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gauvin, David V.</creatorcontrib><creatorcontrib>Zimmermann, Zachary J.</creatorcontrib><creatorcontrib>Kallman, Mary Jeanne</creatorcontrib><title>Establishing performance characteristics for positive control article selection in drug self-administration studies</title><title>Journal of pharmacological and toxicological methods</title><addtitle>J Pharmacol Toxicol Methods</addtitle><description>The selection of a controlled substance (CS) for use as the positive control article in a nonclinical drug abuse liability (DAL) assessment study should be contemplated carefully and with full understanding of the stated intent of the study design. Any CS that can maintain day-to-day stable baseline responding of voluntary intravenous intakes in animals may be selected under the current guidelines. Schedule I – IV CNS stimulants, depressants, and sedative/hypnotics can serve as maintenance drugs in these protocols, but not all of these compounds will provide comparatively efficient, robust, and stable daily intakes. Each Sponsor is directed to select a positive control article and training dose that will provide the most balanced, predictive, and scientifically-sound comparison consistent with the mechanism of action or therapeutic target of the test article. The SA study design is not a “one-size-fits-all” assay. This is a discussion of the critical design factors to be considered in selecting the most appropriate positive control article to use for a SA study.</description><subject>Abuse liability testing</subject><subject>DEA</subject><subject>Drug reinforcement</subject><subject>Drug scheduling</subject><subject>FDA</subject><subject>Harmonized guidelines</subject><subject>Rat</subject><subject>Self-administration</subject><issn>1056-8719</issn><issn>1873-488X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LxDAQhoMofv8CQXr00po0bZMcPIj4BYIXD95CNplqlrZZM-mC_96sqx49zTDv-84wDyFnjFaMsu5yWa0N2qmqKVMVrStKxQ45ZFLwspHydTf3tO1KKZg6IEeIS0opV6zZJwecCiVUWx8SvMVkFoPHdz-9FSuIfYijmSwU9t1EYxNEj8lbLLJQrAL65NdZDFOKYShMzNoABcIANvkwFX4qXJzfNpO-NG70U85H861hmp0HPCF7vRkQTn_qMXm5u325eSifnu8fb66fSstlm0pjFNi-444xIfuFMj3wRnKquqbnrcs_1o1UzLmFbR0wI4XrhOo6yZwROXdMLrZrVzF8zIBJjx4tDIOZIMyoayZbKTolebbyrdXGgBih16voRxM_NaN6A1sv9TdsvYGtaa0z7Jw6_zkwL0Zwf5lfutlwtTVA_nLtIWq0HjJc52PGpV3w_x74AnFnlTI</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Gauvin, David V.</creator><creator>Zimmermann, Zachary J.</creator><creator>Kallman, Mary Jeanne</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190501</creationdate><title>Establishing performance characteristics for positive control article selection in drug self-administration studies</title><author>Gauvin, David V. ; Zimmermann, Zachary J. ; Kallman, Mary Jeanne</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-aa9ecf63d1178fb9afe34830964f35d48824891ddbc5de1a87d6796681da7f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Abuse liability testing</topic><topic>DEA</topic><topic>Drug reinforcement</topic><topic>Drug scheduling</topic><topic>FDA</topic><topic>Harmonized guidelines</topic><topic>Rat</topic><topic>Self-administration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gauvin, David V.</creatorcontrib><creatorcontrib>Zimmermann, Zachary J.</creatorcontrib><creatorcontrib>Kallman, Mary Jeanne</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmacological and toxicological methods</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gauvin, David V.</au><au>Zimmermann, Zachary J.</au><au>Kallman, Mary Jeanne</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Establishing performance characteristics for positive control article selection in drug self-administration studies</atitle><jtitle>Journal of pharmacological and toxicological methods</jtitle><addtitle>J Pharmacol Toxicol Methods</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>97</volume><spage>13</spage><epage>23</epage><pages>13-23</pages><issn>1056-8719</issn><eissn>1873-488X</eissn><abstract>The selection of a controlled substance (CS) for use as the positive control article in a nonclinical drug abuse liability (DAL) assessment study should be contemplated carefully and with full understanding of the stated intent of the study design. Any CS that can maintain day-to-day stable baseline responding of voluntary intravenous intakes in animals may be selected under the current guidelines. Schedule I – IV CNS stimulants, depressants, and sedative/hypnotics can serve as maintenance drugs in these protocols, but not all of these compounds will provide comparatively efficient, robust, and stable daily intakes. Each Sponsor is directed to select a positive control article and training dose that will provide the most balanced, predictive, and scientifically-sound comparison consistent with the mechanism of action or therapeutic target of the test article. The SA study design is not a “one-size-fits-all” assay. This is a discussion of the critical design factors to be considered in selecting the most appropriate positive control article to use for a SA study.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>30797952</pmid><doi>10.1016/j.vascn.2019.02.007</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1056-8719 |
ispartof | Journal of pharmacological and toxicological methods, 2019-05, Vol.97, p.13-23 |
issn | 1056-8719 1873-488X |
language | eng |
recordid | cdi_proquest_miscellaneous_2185876983 |
source | Access via ScienceDirect (Elsevier) |
subjects | Abuse liability testing DEA Drug reinforcement Drug scheduling FDA Harmonized guidelines Rat Self-administration |
title | Establishing performance characteristics for positive control article selection in drug self-administration studies |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T00%3A52%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Establishing%20performance%20characteristics%20for%20positive%20control%20article%20selection%20in%20drug%20self-administration%20studies&rft.jtitle=Journal%20of%20pharmacological%20and%20toxicological%20methods&rft.au=Gauvin,%20David%20V.&rft.date=2019-05-01&rft.volume=97&rft.spage=13&rft.epage=23&rft.pages=13-23&rft.issn=1056-8719&rft.eissn=1873-488X&rft_id=info:doi/10.1016/j.vascn.2019.02.007&rft_dat=%3Cproquest_cross%3E2185876983%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2185876983&rft_id=info:pmid/30797952&rft_els_id=S1056871919300097&rfr_iscdi=true |